Organigram Global (OGI) Long-Term Investments (2018 - 2023)
Organigram Global (OGI) posted quarterly Long-Term Investments of $3.9 million for Q3 2023, down 19.28% on a QoQ basis from $4.9 million in Q3 2022.
Organigram Global (OGI) Long-Term Investments (2018 - 2023) Analysis & Trends
Organigram Global (OGI) has reported Long-Term Investments for 6 consecutive years, with $3.9 million the latest figure, recorded in Q3 2023.
- Quarterly Long-Term Investments changed N/A year-over-year to $3.9 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $3.9 million (changed N/A YoY) and the FY2023 annual result came in at $3.9 million, changed N/A from the prior year.
- Long-Term Investments eased to $3.9 million in Q3 2023 per OGI's latest filing, from $4.9 million in the prior quarter.
- Over the last five years, Long-Term Investments for OGI reached as high as $12.7 million in Q2 2019 and fell as low as -$12.7 million in Q1 2019.
- A 5-year average of $5.6 million and a median of $5.2 million in 2020 frame the typical range for Long-Term Investments.
- The largest YoY upside for Long-Term Investments was 169.96% in 2020 against a maximum downside of 59.09% in 2020.
- Year by year, Long-Term Investments stood at $8.4 million in 2019, then grew by 11.48% to $9.4 million in 2020, then plunged by 47.86% to $4.9 million in 2021, then retreated by 0.03% to $4.9 million in 2022, then declined by 19.28% to $3.9 million in 2023.
- According to Business Quant data, Long-Term Investments over the past three periods registered $3.9 million, $4.9 million, and $4.9 million for Q3 2023, Q3 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 3.94 Mn |
| Aug 31, 2022 | 4.88 Mn |
| Nov 30, 2021 | 4.88 Mn |
| Aug 31, 2021 | 4.04 Mn |
| May 31, 2021 | 8.52 Mn |
| Feb 28, 2021 | 9.02 Mn |
| Nov 30, 2020 | 9.37 Mn |
| Aug 31, 2020 | 5.21 Mn |
| May 31, 2020 | 5.20 Mn |
| Feb 29, 2020 | 8.89 Mn |
| Aug 31, 2019 | 8.40 Mn |
| May 31, 2019 | 12.72 Mn |
| Feb 28, 2019 | -12.71 Mn |
| Nov 30, 2018 | -12.71 Mn |